Moviprep

Polyethylene glycol 3350 with electrolytes, the active ingredient in Moviprep, is an osmotic laxative presented as a powder for oral solution (sachet) for oral use. It is employed to cleanse the bowel before colonoscopy and sigmoidoscopy procedures in adult patients.

GNH USA supplies Moviprep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export. Its global distribution network ensures timely delivery to end‑users across multiple continents.

Moviprep, an osmotic laxative, is used for bowel cleansing in gastrointestinal endoscopic procedures.

Colonoscopic preparation: provides thorough bowel cleansing to enable clear visualization during colonoscopy. Sigmoidoscopic preparation: clears the distal colon for optimal inspection during sigmoidoscopy. Diagnostic endoscopy: facilitates mucosal assessment by removing fecal material.

Moviprep may cause a range of gastrointestinal and systemic reactions, most of which are mild and transient.

Common Side Effects: - Nausea - Abdominal bloating - Abdominal cramping - Vomiting - Thirst - Mild electrolyte disturbance

Serious or Rare Side Effects: - Severe dehydration - Marked electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Acute renal impairment - Allergic reactions such as rash or angioedema - Colonic perforation (very rare)

Before prescribing Moviprep, clinicians should consider several safety measures.

Assess renal function: evaluate kidney status prior to use. Check electrolyte levels: obtain baseline labs to identify abnormalities. Ensure adequate hydration: patients must drink the recommended fluid volume. Avoid in bowel obstruction: contraindicated in mechanical obstruction. Use caution in elderly: monitor for fluid and electrolyte shifts. Store at ambient temperature: keep in original pack, protect from moisture.

Moviprep can interact with other medications, requiring attention to potential risks.

Major Interactions (Avoid): - Concomitant use with other osmotic laxatives: risk of severe electrolyte loss. - Loop diuretics: may exacerbate dehydration and electrolyte disturbances. - Sodium‑containing IV fluids: can cause hypernatremia when combined.

Moderate Interactions (Monitor Closely): - Antacids: may alter taste but no major effect. - Certain antibiotics (e.g., quinolones): rapid transit may reduce absorption. - Mineral supplements (e.g., calcium, iron): may affect electrolyte balance. - NSAIDs: combined renal stress may increase risk of kidney injury.